Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 16, 2011
Tue, February 15, 2011 BRKS, ASTM, HQL, SVNT, CRA, AXS Are Seasonally Ripe To Go Down In the Next Five Weeks
February 15, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of BROOKS AUTOMATION INC (NASDAQ:BRKS), AASTROM BIOSCIENCES INC (NASDAQ:ASTM), H & Q LIFE SCIENCES INVSTRS (NYSE:HQL), SAVIENT PHARMACEUTICALS INC (NASDAQ:SVNT), CELERA CORP (NASDAQ:CRA), AXIS CAPITAL HOLDINGS LTD (NYSE:AXS) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date
BRKS BROOKS AUTOMATION INC -6.090 % 75.00% (12 of 16) Wednesday, March 30th 2011
ASTM AASTROM BIOSCIENCES INC -14.400 % 85.71% (12 of 14) Tuesday, March 29th 2011
HQL H & Q LIFE SCIENCES INVSTRS -6.460 % 88.89% (16 of 18) Tuesday, March 29th 2011
SVNT SAVIENT PHARMACEUTICALS INC -13.100 % 90.48% (19 of 21) Monday, March 28th 2011
CRA CELERA CORP -8.930 % 63.64% (7 of 11) Monday, March 28th 2011
AXS AXIS CAPITAL HOLDINGS LTD -6.240 % 85.71% (6 of 7) Friday, March 25th 2011
BROOKS AUTOMATION INC (NASDAQ:BRKS) - Brooks Automation, Inc. provides automation, vacuum, and instrumentation solutions primarily to the semiconductor manufacturing industry worldwide. It operates in three segments: Critical Solutions Group, Systems Solutions Group, and Global Customer Operations. The Critical Solutions Group segment provides various products, including robots and robotic modules for atmospheric and vacuum applications; cryogenic vacuum pumping systems; thermal management; and vacuum measurement solutions to create, measure, and control critical process vacuum applications. The Systems Solutions Group segment provides a range of products, and engineering and manufacturing services that enable the companys customers to develop and source process tools for semiconductor market applications, as well as manufactures products based on a customer specified design. The Global Customer Operations segment provides support services, including on and off-site repair services, on and off-site diagnostic support services, and installation services. This segment also provides services and spare parts for the companys automated material handling systems product line. Brooks Automation also serves customers in data storage, advanced display, analytical instruments, and solar markets. The company was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
AASTROM BIOSCIENCES INC (NASDAQ:ASTM) - Aastrom Biosciences, Inc. engages in developing autologous cell products for the treatment of severe, chronic, and cardiovascular diseases. The company's proprietary tissue repair cell (TRC) technology expands the numbers of stem and early progenitor cells from a small amount of bone marrow collected from the patient. The company is conducting a Phase II cardiac regeneration clinical trial (the IMPACT-DCM trial) in patients with dilated cardiomyopathy (DCM severe chronic heart failure) and a Phase IIb vascular regeneration clinical trial (the RESTORE-CLI trial) in patients with critical limb ischemia (CLI the most severe form of peripheral arterial disease). Aastrom Biosciences would also initiate its U.S. Phase II clinical trial to evaluate the catheter delivery of CRCs for the treatment of DCM. The company was founded in 1989 and is headquartered in Ann Arbor, Michigan.
H & Q LIFE SCIENCES INVSTRS (NYSE:HQL) - H&Q Life Sciences Investors
SAVIENT PHARMACEUTICALS INC (NASDAQ:SVNT) - Savient Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing KRYSTEXXA, a biologic PEGylated uricase in the United States. The KRYSTEXXA is being developed as a treatment for chronic gout in patients refractory to conventional therapy. The company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. It sells its products directly to drug wholesalers. The company, formerly known as Bio-Technology General Corp. and changed its name to Savient Pharmaceuticals, Inc. in June 2003. Savient Pharmaceuticals, Inc. was founded in 1980 and is headquartered in East Brunswick, New Jersey.
CELERA CORP (NASDAQ:CRA) - Celera Corporation offers personalized disease management through a combination of products and services primarily in the United States. The companys Lab Services segment provides a portfolio of clinical laboratory tests and disease management services designed to help physicians improve cardiovascular disease treatment regimens for their patients. This segment offers clinical laboratory testing services that characterize and monitor cardiovascular disease risks; and personalized and ongoing therapeutic compliance education. It also provides principal tests, including LDL-S3GGE test that measures low-density lipoprotein (LDL) size as a subclass distribution divided in seven regions and characterizes the amount of LDL distributed in these regions; HDL-S10GGE test that measures high-density lipoprotein (HDL) size as a subclass distribution divided across five HDL regions and characterizes the amount of HDL distributed in these regions; Kinesin-Like Protein 6 (KIF6) test, which detects a variant in a gene called KIF6; and LPA genotype test to detect a variant of the LPA gene known as 4399Met. Its Products segment develops and manufactures molecular diagnostic products for disease detection, prediction of disease predisposition, monitoring of disease progression and disease severity, and determination of patient responsiveness to treatments. Celera Corporation has a strategic alliance with Abbott Laboratories to discover, develop, and commercialize molecular diagnostic products for disease detection, prediction of disease predisposition, disease progression monitoring, and therapy selection. The companys Corporate segment licenses small molecule drug development programs and Life Technologies intellectual property to third parties for use in the diagnostic field; and establishes collaborations to develop cancer therapies based on its proteomics discoveries. Celera Corporation was founded in 1998 and is headquartered in Alameda, California.
AXIS CAPITAL HOLDINGS LTD (NYSE:AXS) - AXIS Capital Holdings Limited, through its subsidiaries, provides various insurance and reinsurance products to insureds and reinsureds worldwide. It operates in two segments, Insurance and Reinsurance. The Insurance segment provides specialty insurance products, including property, marine, terrorism, aviation, credit and political risk, professional lines, liability, and employee medical coverage for self-insured, and small and medium sized employers. This segment offers its products through wholesale and retail brokers, managing general agents, and underwriters. The Reinsurance segment provides non-life reinsurance to insurance companies. Its product lines include catastrophe, which protects catastrophic losses; property that covers underlying personal lines and commercial property exposures; professional liability covering directors and officers liability, employment practices liability, medical malpractice, lawyers and accountants liability, environmental liability, and miscellaneous errors and omissions insurance risks; credit and bond, which include reinsurance of trade credit insurance products; motor coverage to insurers for motor liability losses; liability coverage, such as auto liability, general liability, and workers compensation; engineering coverage for various construction risks and risks associated with erection, testing, and commissioning of machinery and plants during the construction stage; and other products, including aviation, marine, personal accident, and crop reinsurance. In addition, AXIS Capital Holdings provides accident and health line products covering corporate personal accident and business travel accident products, association/affinity programs, and student accident and catastrophic health products. The company was founded in 2001 and is headquartered in Pembroke, Bermuda.
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
- WOPRAI
- support@woprai.com